These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7677218)
21. Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Asilian A; Davami M Clin Exp Dermatol; 2006 Sep; 31(5):634-7. PubMed ID: 16780497 [TBL] [Abstract][Full Text] [Related]
22. Randomized, double-blinded, phase 2 trial of WR 279,396 (paromomycin and gentamicin) for cutaneous leishmaniasis in Panama. Sosa N; Capitán Z; Nieto J; Nieto M; Calzada J; Paz H; Spadafora C; Kreishman-Deitrick M; Kopydlowski K; Ullman D; McCarthy WF; Ransom J; Berman J; Scott C; Grogl M Am J Trop Med Hyg; 2013 Sep; 89(3):557-563. PubMed ID: 23857024 [TBL] [Abstract][Full Text] [Related]
23. Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study. Weinrauch L; Cawich F; Craig P; Sosa JX; el-On J J Am Acad Dermatol; 1993 Sep; 29(3):443-6. PubMed ID: 8349861 [TBL] [Abstract][Full Text] [Related]
24. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin. Grogl M; Schuster BG; Ellis WY; Berman JD J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319 [TBL] [Abstract][Full Text] [Related]
25. Aminosidine (paromomycin) versus sodium stibogluconate for the treatment of American cutaneous leishmaniasis. Hepburn NC; Tidman MJ; Hunter JA Trans R Soc Trop Med Hyg; 1994; 88(6):700-3. PubMed ID: 7886779 [TBL] [Abstract][Full Text] [Related]
26. Leishmania major: resistance of promastigotes to paromomycin, and susceptibility of amastigotes to paromomycin-methylbenzethonium chloride ointment. el-On J; Sulitzeanu A; Schnur LF Ann Trop Med Parasitol; 1991 Jun; 85(3):323-8. PubMed ID: 1746981 [TBL] [Abstract][Full Text] [Related]
28. Treatment of 'Old World' cutaneous leishmaniasis with aminosidine ointment: results of an open study in London. Bryceson AD; Murphy A; Moody AH Trans R Soc Trop Med Hyg; 1994; 88(2):226-8. PubMed ID: 8036683 [TBL] [Abstract][Full Text] [Related]
29. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions. Schwartz J; Moreno E; Calvo A; Blanco L; Fernández-Rubio C; Sanmartín C; Nguewa P; Irache JM; Larrea E; Espuelas S J Dermatol Sci; 2018 Oct; 92(1):78-88. PubMed ID: 30037731 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Armijos RX; Weigel MM; Calvopiña M; Mancheno M; Rodriguez R Acta Trop; 2004 Jul; 91(2):153-60. PubMed ID: 15234664 [TBL] [Abstract][Full Text] [Related]
31. Injectable paromomycin for Visceral leishmaniasis in India. Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067 [TBL] [Abstract][Full Text] [Related]
32. Treatment of cutaneous leishmaniasis by photodynamic therapy. Gardlo K; Horska Z; Enk CD; Rauch L; Megahed M; Ruzicka T; Fritsch C J Am Acad Dermatol; 2003 Jun; 48(6):893-6. PubMed ID: 12789181 [TBL] [Abstract][Full Text] [Related]
33. Hexadecyl-phosphorylcholine ointment for treatment of cutaneous leishmaniasis: an animal trial. Iqbal J; Bukhari I; Jamshid M; Bashir S; Masoom Yasinzai M; Anwar M East Mediterr Health J; 2006 Sep; 12(5):685-9. PubMed ID: 17333810 [TBL] [Abstract][Full Text] [Related]
34. Topical paromomycin/methylbenzethonium chloride plus parenteral meglumine antimonate as treatment for American cutaneous leishmaniasis: controlled study. Soto J; Fuya P; Herrera R; Berman J Clin Infect Dis; 1998 Jan; 26(1):56-8. PubMed ID: 9455509 [TBL] [Abstract][Full Text] [Related]
35. [Spontaneous course of lesions of Leishmania major cutaneous leishmaniasis in Tunisia]. Zakraoui H; Ben Salah A; Ftaiti A; Marrakchi H; Zaatour A; Zaafouri B; Ahmadi Z; Garraoui A; Ben Osman A; Dellagi K Ann Dermatol Venereol; 1995; 122(6-7):405-7. PubMed ID: 8526421 [TBL] [Abstract][Full Text] [Related]
36. Histological and immunological differences between zoonotic cutaneous leishmaniasis due to Leishmania major and sporadic cutaneous leishmaniasis due to Leishmania infantum. Boussoffara T; Boubaker MS; Ben Ahmed M; Mokni M; Guizani I; Ben Salah A; Louzir H Parasite; 2019; 26():9. PubMed ID: 30810524 [TBL] [Abstract][Full Text] [Related]
37. Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride. el-On J; Weinrauch L; Livshin R; Even-Paz Z; Jacobs GP Br Med J (Clin Res Ed); 1985 Sep; 291(6497):704-5. PubMed ID: 3929905 [No Abstract] [Full Text] [Related]
38. Spread of Leishmania killicki to Central and South-West Tunisia. Bouratbine A; Aoun K; Ghrab J; Harrat Z; Ezzedini MS; Etlijani S Parasite; 2005 Mar; 12(1):59-63. PubMed ID: 15828583 [TBL] [Abstract][Full Text] [Related]
39. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828 [TBL] [Abstract][Full Text] [Related]
40. Studies on the topical treatment of experimental cutaneous leishmaniasis: the therapeutic effect of methyl benzethonium chloride and the aminoglycosides, gentamicin and paromomycin. Carter KC; Alexander J; Baillie AJ Ann Trop Med Parasitol; 1989 Jun; 83(3):233-9. PubMed ID: 2604461 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]